Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Appointed director

MyMD Pharmaceuticals, Inc. (AKER) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 4 Rivard Paul (Chief Legal Officer) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Bought 150,000 shares @ $1.11, valued at $166.5k
08/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2023 4 Chapman Christopher C JR (President, Chief Med. Officer) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 300,000 options to buy @ $1.66, valued at $498k
06/09/2023 4 Kaplin Adam (Chief Scientific Officer) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 150,000 options to buy @ $1.66, valued at $249k
06/09/2023 4 Uzonwanne Jude (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 150,000 options to buy @ $1.66, valued at $249k
06/09/2023 4 Schreiber Christopher C (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 150,000 options to buy @ $1.66, valued at $249k
06/09/2023 4 EAGLE CRAIG (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 475,000 options to buy @ $1.66, valued at $788.5k
06/09/2023 4 Silverman Joshua (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 200,000 options to buy @ $1.66, valued at $332k
06/09/2023 4 White Billy Joe (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 150,000 options to buy @ $1.66, valued at $249k
06/09/2023 4 Rivard Paul (Chief Legal Officer) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 150,000 options to buy @ $1.66, valued at $249k
04/05/2023 4 Chapman Christopher C JR (President, Chief Med. Officer) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 750,000 options to buy @ $1.55, valued at $1.2M
12/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/29/2021 4 Silverman Joshua (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Bought 6,734 shares @ $6.2991, valued at $42.4k
Bought 3,266 shares @ $7.0937, valued at $23.2k
Bought 5,000 shares @ $7.5543, valued at $37.8k
11/24/2021 4 Rivard Paul (EVP of Operations, GC) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Bought 15,000 shares @ $6.03, valued at $90.5k
10/15/2021 4 Kaplin Adam (Chief Scientific Officer) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 600,000 restricted stock units @ $0
10/15/2021 4 Schreiber Christopher C (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 150,000 restricted stock units @ $0
10/15/2021 4 White Billy Joe (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 150,000 restricted stock units @ $0
10/15/2021 4 Uzonwanne Jude (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 150,000 restricted stock units @ $0
10/15/2021 4 EAGLE CRAIG (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 150,000 restricted stock units @ $0
10/15/2021 4 Silverman Joshua (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 600,000 restricted stock units @ $0
10/15/2021 4 Chapman Christopher C JR (President, Chief Med. Officer) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 600,000 restricted stock units @ $0
10/15/2021 4 Rivard Paul (EVP of Operations, GC) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 200,000 restricted stock units @ $0
04/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/21/2021 4 Kaplin Adam (Chief Scientific Officer) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 154,360 options to buy @ $2.5913, valued at $400k
04/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/21/2021 4 Uzonwanne Jude (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 115,770 options to buy @ $2.5913, valued at $300k
04/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2021 4 Rivard Paul (EVP of Operations, GC) has filed a Form 4 on MyMD Pharmaceuticals, Inc.
Txns: Granted 77,180 options to buy @ $2.5913, valued at $200k
Granted 77,180 options to buy @ $2.5913, valued at $200k
04/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/11/2020 4 White Billy Joe (Director) has filed a Form 4 on Akers Biosciences, Inc.
Txns: Granted 219,000 restricted stock units @ $0
09/11/2020 4 Silverman Joshua (Director) has filed a Form 4 on Akers Biosciences, Inc.
Txns: Granted 219,000 restricted stock units @ $0
09/11/2020 4 SCHROEDER ROBERT C (Director) has filed a Form 4 on Akers Biosciences, Inc.
Txns: Granted 87,860 restricted stock units @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy